Caitong International Asset Management’s Pulse Biosciences PLSE Stock Holding History

Caitong International Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14K	Buy	+53	New	+$978	﹤0.01%	1389

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Caitong International Asset Management's PLSE Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 53 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #1389 among its holdings.

96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

Caitong International Asset Management held 53 shares of Pulse Biosciences worth $1.14K as of Q1 2026.
Pulse Biosciences was a new Caitong International Asset Management position in Q1 2026.
Pulse Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1389 holding.
96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.